Natriuretic Peptides for the Detection of Paroxysmal Atrial Fibrillation in Patients with Cerebral Ischemia – the Find-AF Study
Open Access
- 11 April 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (4) , e34351
Abstract
Diagnosis of paroxysmal atrial fibrillation (AF) can be challenging, but it is highly relevant in patients presenting with sinus rhythm and acute cerebral ischemia. We aimed to evaluate prospectively whether natriuretic peptide levels and kinetics identify patients with paroxysmal AF. Patients with acute cerebral ischemia were included into the prospective observational Find-AF study. N-terminal pro brain-type natriuretic peptide (NT-proBNP), brain-type natriuretic peptide (BNP) and N-terminal pro atrial-type natriuretic peptide (NT-proANP) plasma levels were measured on admission, after 6 and 24 hours. Patients free from AF at presentation received 7 day Holter monitoring. We prospectively hypothesized that patients presenting in sinus rhythm with NT-proBNP>median were more likely to have paroxysmal AF than patients with NT-proBNPmedian (239 pg/ml), 17.9% had paroxysmal AF in contrast to 7.4% with NT-proBNP<239 pg/ml (p = 0.025). The ratio of early (0 h) to late (24 h) plasma levels of NT-proBNP showed no difference between both groups. For the detection of paroxysmal atrial fibrillation, BNP, NT-proBNP and NT-proANP at admission had an area under the curve in ROC analysis of 0.747 (0.663–0.831), 0.638 (0.531–0.744) and 0.663 (0.566–0.761), respectively. In multivariate analysis, BNP was the only biomarker to be independently predictive for paroxysmal atrial fibrillation. BNP is independently predictive of paroxysmal AF detected by prolonged ECG monitoring in patients with cerebral ischemia and may be used to effectively select patients for prolonged Holter monitoring.Keywords
This publication has 22 references indexed in Scilit:
- Cryptogenic Stroke and underlying Atrial Fibrillation (CRYSTAL AF): Design and rationaleAmerican Heart Journal, 2010
- Relations of Biomarkers of Distinct Pathophysiological Pathways and Atrial Fibrillation Incidence in the CommunityCirculation, 2010
- N-Terminal Pro-B-Type Natriuretic Peptide Is a Major Predictor of the Development of Atrial FibrillationCirculation, 2009
- Brain Natriuretic Peptide as a Surrogate Marker for Cardioembolic Stroke with Paroxysmal Atrial FibrillationCerebrovascular Diseases, 2008
- Risks and Benefits of Oral Anticoagulation Compared With Clopidogrel Plus Aspirin in Patients With Atrial Fibrillation According to Stroke RiskStroke, 2008
- Transrectal EUS-guided FNA biopsy of a presacral chordoma-report of a case and review of the literatureWorld Journal of Gastroenterology, 2008
- Noninvasive Cardiac Monitoring for Detecting Paroxysmal Atrial Fibrillation or Flutter After Acute Ischemic StrokeStroke, 2007
- N-Terminal Pro-Brain Natriuretic Peptide Levels Are Elevated in Patients with Acute Ischemic StrokeAngiology, 2005
- Effect of sinus rhythm restoration on plasma brain natriuretic peptide in patients with atrial fibrillationThe American Journal of Cardiology, 2004
- Atrial fibrillation as an independent risk factor for stroke: the Framingham Study.Stroke, 1991